RPS6KA1 and neoplasm: Zhang et al. demonstrated that TIMM50 facilitated tumor proliferation and invasion of non-small cell lung cancer (NSCLC) through enhancing phosphorylation of its downstream ERK/P90RSK signaling pathway, and speculated that TIMM50 might be a useful prognosis marker for NSCLC patients [36].